Nefopam inhibits calcium influx, cGMP formation, and NMDA receptor-dependent neurotoxicity following activation of voltage sensitive calcium channels.
about
Rediscovery of nefopam for the treatment of neuropathic painStatus epilepticus caused by nefopamNefopam Reduces Dysesthesia after Percutaneous Endoscopic Lumbar Discectomy.Overview of adverse reactions to nefopam: an analysis of the French Pharmacovigilance database.The Role of Spinal Dopaminergic Transmission in the Analgesic Effect of Nefopam on Rat Inflammatory PainComparison of effects of intraoperative nefopam and ketamine infusion on managing postoperative pain after laparoscopic cholecystectomy administered remifentanil.Ondansetron does not attenuate the analgesic efficacy of nefopam.Spinal noradrenergic modulation and the role of the alpha-2 receptor in the antinociceptive effect of intrathecal nefopam in the formalin test.Intravenous Nefopam Reduces Postherpetic Neuralgia during the Titration of Oral Medications.The analgesic effect of nefopam combined with low dose remifentanil in patients undergoing middle ear surgery under desflurane anesthesia: a randomized controlled trial.Comparison of effect of electroacupuncture and nefopam for prevention of postanesthetic shivering in patients undergoing urologic operation under spinal anesthesia.Effects of nefopam on emergence agitation after general anesthesia for nasal surgery: A prospective, randomized, and controlled trial.Systematic evaluation of the nefopam-paracetamol combination in rodent models of antinociception.Pharmacokinetics, distribution, metabolism, and excretion of the dual reuptake inhibitor [(14)C]-nefopam in rats.Pharmacokinetics, metabolism, and excretion of nefopam, a dual reuptake inhibitor in healthy male volunteers.Effects of nefopam on catheter-related bladder discomfort in patients undergoing ureteroscopic litholapaxy.
P2860
Q26998691-9168D551-7EF0-4241-98F6-F2F4AB84A938Q34749904-A1468106-FED2-4B8C-915D-5788DCB5224DQ36516325-9D32108C-57A6-49CF-A248-CE115207B839Q36941963-A90EBD35-C021-46B6-A738-DB2D6EF05311Q37089209-864593C2-44DF-4020-8C1F-F4E5D48D5247Q37306610-90623611-47D3-4453-AF78-E4E19662934EQ37334068-E0183307-A82C-4661-8649-B8F0B456CDB5Q37521604-A06992DB-8297-482C-A379-919F0BDF73B4Q37521631-C6F85992-1BD0-455A-8D7E-DD811BF05187Q41994168-1EA9EA0E-8B6D-41EC-9327-524576BDD1F4Q42360061-377B05EF-D7BE-470F-BFE0-0BEEE60457F8Q47098768-8C0BE79D-61CC-4A6F-939F-7D227AD904A8Q48296383-A3D19F14-47C0-4EDF-A90E-418DEE0D2249Q50251124-63423FCE-5072-4330-B871-C2D97EDE97D8Q55059545-42960EAA-045A-42A1-AC08-55039D22852CQ55332858-71204C27-BAD0-4AF4-906D-8256FF444529
P2860
Nefopam inhibits calcium influx, cGMP formation, and NMDA receptor-dependent neurotoxicity following activation of voltage sensitive calcium channels.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Nefopam inhibits calcium influ ...... ge sensitive calcium channels.
@en
Nefopam inhibits calcium influ ...... ge sensitive calcium channels.
@nl
type
label
Nefopam inhibits calcium influ ...... ge sensitive calcium channels.
@en
Nefopam inhibits calcium influ ...... ge sensitive calcium channels.
@nl
prefLabel
Nefopam inhibits calcium influ ...... ge sensitive calcium channels.
@en
Nefopam inhibits calcium influ ...... ge sensitive calcium channels.
@nl
P2093
P1433
P1476
Nefopam inhibits calcium influ ...... ge sensitive calcium channels.
@en
P2093
Fernández-Sánchez MT
Groppetti A
P2888
P304
P356
10.1007/S00726-005-0166-0
P577
2005-02-18T00:00:00Z
P6179
1050706519